Hikma Pharmaceuticals said on Thursday that U.S. regulators had decided not to approve its generic copy of GlaxoSmithKline’s blockbuster lung drug Advair at this time, due to ‘major’ issues with its application. More »
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor/File Photo Mylan NV said on Wednesday the U.S. Food and Drug Administration declined to approve its generic version of GlaxoSmithKline Plc’s (GSK.L) blockbu... More »
Signage for GlaxoSmithKline is seen on it’s offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo A deadline for U.S. regulators to give a verdict on a generic copy of GlaxoSmithKline’s blockbuster inhaled lung drug Advair has passed wit... More »
